Clearstead Trust, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Clearstead Trust, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$117,787
-14.6%
3,121
-8.2%
0.04%
-11.4%
Q2 2023$137,9450.0%3,4010.0%0.04%0.0%
Q1 2023$137,945
+79637.0%
3,4010.0%0.04%
-24.1%
Q4 2022$173
-99.9%
3,4010.0%0.06%
-9.4%
Q3 2022$183,000
-17.9%
3,401
-2.1%
0.06%
-62.4%
Q2 2022$223,000
-17.1%
3,4730.0%0.17%
-2.3%
Q1 2022$269,000
-9.7%
3,4730.0%0.17%
-1.1%
Q4 2021$298,000
+5.3%
3,473
-1.4%
0.18%
-1.7%
Q3 2021$283,000
-0.4%
3,5240.0%0.18%
-3.2%
Q2 2021$284,000
-4.4%
3,5240.0%0.18%
-15.9%
Q1 2021$297,000
+4.9%
3,5240.0%0.22%
+31.0%
Q4 2020$283,0000.0%3,5240.0%0.17%
-25.3%
Q3 2020$283,000
-6.6%
3,5240.0%0.22%
-11.8%
Q2 2020$303,000
+5.9%
3,5240.0%0.26%
-1.5%
Q1 2020$286,000
-49.1%
3,524
-47.6%
0.26%
-37.1%
Q4 2019$562,000
-16.9%
6,724
-12.9%
0.41%
-21.8%
Q3 2019$676,000
+3.8%
7,724
-2.8%
0.53%
+1.3%
Q2 2019$651,000
+0.6%
7,9490.0%0.52%
-3.7%
Q1 2019$647,000
-99.9%
7,949
-54.6%
0.54%
+0.9%
Q4 2018$576,435,000
+17669.3%
17,498
-58.4%
0.54%
-78.5%
Q3 2018$3,244,000
+8.1%
42,080
+3.5%
2.49%
-7.2%
Q2 2018$3,002,000
+10.4%
40,655
-2.8%
2.68%
+14.9%
Q1 2018$2,720,000
-5.1%
41,823
-5.7%
2.33%
+19.1%
Q4 2017$2,867,000
+5.9%
44,347
+2.8%
1.96%
-2.7%
Q3 2017$2,707,000
+3.8%
43,146
+1.7%
2.01%
-2.2%
Q2 2017$2,609,000
+21.1%
42,430
+2.1%
2.06%
+15.4%
Q1 2017$2,155,000
+17.5%
41,539
+0.4%
1.78%
+8.3%
Q4 2016$1,834,00041,3591.65%
Other shareholders
BAXTER INTL INC shareholders Q4 2020
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders